Biodegradable controlled-release microcapsules
By combining protein-based components with isocyanates and chlorine-containing crosslinking agents to form biodegradable microcapsules, the problems of difficult degradation and insufficient performance of microcapsule wall materials are solved, enabling controlled release and improved physical properties suitable for a variety of commercial applications.
Patent Information
- Application Number
- CN202580024858.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-05-27
- Filing Date
- 2025-03-26
- Publication Date
- 2026-11-10
AI Technical Summary
Existing microcapsule wall materials are difficult to biodegrade and have shortcomings in terms of physical properties and performance, failing to meet the diverse needs of commercial applications, especially in terms of controlled release characteristics and integrity.
By using a combination of protein-based components and two or more cross-linking agents, including isocyanates and chlorinated components, microcapsule walls are formed through a reaction in a specific weight ratio, providing controlled release characteristics and improved physical properties.
The production of biodegradable microcapsules with improved physical properties such as strength and fragility makes them suitable for a variety of applications, including printing, adhesives and sealants, washing and fabric treatment.
Smart Images

Figure SMS_1 
Figure SMS_2
Abstract
Description
Related applications
[0001] This application claims the benefit of U.S. Provisional Patent Application No. 63 / 570,846, entitled “Biodegradable Controlled-Release Microcapsules,” filed March 28, 2024, and U.S. Provisional Patent Application No. 63 / 652,092, entitled “Biodegradable Controlled-Release Microcapsules,” filed May 27, 2024, the contents of which are incorporated herein by reference in their entirety. Technical Field
[0002] This disclosure relates to biodegradable controlled-release microcapsules, the microcapsule walls of which comprise reaction products of one or more protein-based components and at least two different cross-linking agents, the protein-based components being selected from proteins, peptides and / or polypeptides, and at least one of the cross-linking agents being an isocyanate component and the other being a chlorine-containing component. Background Technology
[0003] Microcapsules and microencapsulation technology are well-established and widely known, with diverse commercial applications. Microcapsules play a crucial role in various printing technologies, where paper or other similar substrates are coated with microcapsules containing ink, inking, or inducing ink components. When pressure, such as through a printing press or stylus, ruptures the microcapsules, these components are released, forming an image. Microcapsules also play a significant role in various adhesive and sealant technologies, including encapsulating solvents for solvent-swellable / tackifying pre-coated adhesives. In this process, the solvent released upon microcapsule rupture softens or tackifies the adhesive, achieving bonding, and the adhesive re-hardens as the solvent evaporates. In other adhesive and sealant applications, microcapsules contain components of one or more curable or polymerizable adhesive or sealant compositions, which, upon release, can cause the adhesive or sealant to cure or polymerize. In all these early applications, functionality and efficacy (especially in terms of long-term storage and usability) depended on the integrity of the microcapsule wall, which was sought after in terms of both strength to avoid premature rupture and impermeability to prevent leakage and / or penetration of the microcapsule contents through the wall. In the former case, components pre-coated with microcapsule adhesive tend to stick together if they collide with or stack together under sufficiently high stacking pressure. Even if not bonded, the rupture of the microcapsules would result in less adhesive available for bonding when it was intended. Similarly, if the microcapsule wall allowed the active ingredient to permeate through the wall, even slowly, it would shorten product life because it would lead to unintended curing.
[0004] As with most technologies, the development of microencapsulation technology has led to many new applications, including some that require alterations to the physical properties of the microcapsules, particularly their walls. New applications require microcapsules to rupture more easily with less pressure, but without premature rupture. Other applications require microcapsules to allow for controlled, slow release or permeation of their contents without actually rupturing the microcapsule itself. For example, fragrance-containing microcapsules are often used in magazine inserts so readers can sample the fragrance. Strength is needed to prevent premature rupture due to the magazine's weight and handling; however, the microcapsules need to be easily ruptured so that readers can simply scrape the treated area to release the contents. Ideally, even if the microcapsule doesn't rupture, some contents should be released to encourage readers to scrape the sample for a more accurate fragrance experience.
[0005] Another application of microcapsules is in washing and fabric treatment. Currently, many products exist where microcapsules containing various ingredients (including fragrances) are applied to strips of fabric material and then placed in a dryer; the tumbling action and / or high temperature of the dryer cause the microcapsules to rupture, releasing the ingredients, which then permeate and deposit on the contents inside the dryer in a volatile state. This method imparts a "fresh out of the dryer" fragrance, but its lifespan is short because the fragrance continues to evaporate from the treated fabric. Other products involve applying microcapsules containing fragrances and other ingredients directly or indirectly to fabrics, particularly clothing, to prolong the freshness of the fabric. The performance or efficacy of these products tends to be short-lived because the contents of the microcapsules easily escape from the microcapsules, and / or the microcapsule walls are too weak, and / or too inelastic, making the microcapsules easily rupture during normal wear of the fabric.
[0006] Whether applications have driven the evolution of microencapsulation technology, or the evolution of microencapsulation technology has driven the expansion of its applications, or both, microencapsulation technology has been continuously evolving in its production / processing methods and chemistry. Early melamine-formaldehyde microcapsules have continued to evolve; however, they have also been superseded to some extent by acrylic acid and other microencapsulation chemistry and technology. Furthermore, both have evolved into their respective chemistry and double-walled microcapsules combining both chemistry. While the basic building blocks of the capsule wall remain largely unchanged, the specific choices of building blocks and methods have led to newer, improved microcapsules, enabling the microencapsulation of a wider range of ingredients, compounds, and elements.
[0007] With the aforementioned advancements and improvements, and the continued expansion of microcapsules across numerous applications, the accumulation of microcapsules in the environment, and subsequently in animal species that feed on substances containing and / or contaminated with microcapsules, is increasing. Unfortunately, these microcapsules are made of synthetic polymer materials and can remain in the environment for decades, even centuries. Although various governments / regulatory bodies have not yet mandated it, action is being taken to control the use of such polymer microcapsules.
[0008] Therefore, there is a growing, and perhaps some would consider urgent, demand for microcapsules with biodegradable walls. Although capsules, and in some cases microcapsules, have been tested, particularly for their use in the pharmaceutical and nutritional supplement industries, the walls of these microcapsules are formed from gelatin, albumin, polylactide, and poly(lactide-co-glycolic acid), all of which are generally considered biodegradable. However, these materials and their properties make them difficult to use, especially in the production of microcapsules. Furthermore, the resulting microcapsules are inferior in physical properties and performance compared to conventional, typically non-biodegradable, microcapsules. Microcapsules are also formed from block peptides; however, similarly, their properties and performance are limited: clearly unsuitable for the numerous commercial applications of conventional microcapsules. Moreover, their production method, solvent evaporation, is unsuitable for large-scale commercial production; not to mention the encapsulation of a wide range of materials that can be microencapsulated using more conventional microencapsulation techniques.
[0009] Despite progress, particularly from a biodegradability perspective, the need to balance biodegradability with the performance characteristics of the microcapsule wall persists. Specifically, while improved biodegradable microcapsules have been developed using selected peptides and gelatin with isocyanate crosslinking agents (see, for example, US 11,952,492B2 and US Patent Application Publication No. 2023 / 0112578A1), there remains a need to address the integrity and performance of the capsule wall, and the desire to control or precisely set specific performance characteristics to facilitate the production of unique / customized microcapsules for specific end-use applications.
[0010] As will be discussed below, it has now been found that by using multiple cross-linking agents of different chemicals simultaneously, it is possible to produce further improved biodegradable microcapsules and / or better control over the physical properties and release characteristics of such biodegradable microcapsules. Summary of the Invention
[0011] According to this teaching, microcapsules and methods for their production are provided, wherein the microcapsules comprise a reaction product of the following components: A) one or more protein-based components selected from proteins, peptides, and / or polypeptides, and B) a crosslinking component comprising a combination of two or more crosslinking agents, at least one of which is i) an isocyanate component selected from one or more diisocyanates and / or polyisocyanates, and at least one of which is ii) a chlorine-containing component selected from a) diacid chlorides and / or polyacrylic chlorides, b) dichloroformates and / or polyisocyanates. Chloroformate and / or c) disulfonyl chloride and / or polysulfonyl chloride; wherein (I) the weight ratio (A:B) of the protein-based component to the crosslinking component is 100:1 to 1:100, preferably 50:1 to 1:50, more preferably 10:1 to 1:10, particularly 1:5 to 1:0.2, most preferably 1:2 to 1:1, and (II) the weight ratio (i:ii) of the isocyanate component to the chlorine-containing component is 100:1 to 100:50, preferably 100:2.5 to 100:25, more preferably 100:5 to 100:15, most preferably 100:7.5 to 100:12.5.
[0012] The microencapsulation method described in this teaching is used to provide carrier microcapsules containing various core materials, including solids, hydrophilic agents, hydrophobic agents, lipophilic agents, etc., particularly UV absorbers, UV reflectors, pigments, dyes, colorants, scale inhibitors, corrosion inhibitors, antioxidants, pour point depressants, waxes, deposition inhibitors, dispersants, flame retardants, biocides, reactive dye tracers, odor control agents, natural oils, flavoring oils and essential oils, crop protectants, drugs, pharmaceuticals, phase change materials, etc. Detailed Implementation
[0013] This teaching relates to novel microcapsules and methods for their preparation. Specifically, the microcapsules of this teaching are biodegradable and serve as carriers for various core materials contained therein, including solids, hydrophilic agents, hydrophobic agents, lipophilic agents, etc. Most specifically, the carrier microcapsules of this teaching are biodegradable and possess controlled-release properties and / or modified or customized physical properties, such as strength, fragility, etc., for the liquid / volatile core material contained therein, for its intended purpose.
[0014] According to this teaching, microcapsules and methods for their production are provided, wherein the microcapsules comprise a reaction product comprising: A) one or more protein-based components selected from proteins, peptides, and / or polypeptides, and B) a crosslinking component comprising a combination of two or more crosslinking agents, at least one of which is i) an isocyanate component selected from one or more diisocyanates and / or polyisocyanates, and at least one of which is ii) a chlorine-containing component selected from a) diacyl chlorides and / or polyacyl chlorides, b) dichloroformates and / or polychlorinated compounds. Formate and / or c) disulfonyl chloride and / or polysulfonyl chloride; wherein (I) the weight ratio (A:B) of the protein-based component to the crosslinking component is 100:1 to 1:100, preferably 50:1 to 1:50, more preferably 10:1 to 1:10, particularly 1:5 to 1:0.2, most preferably 1:2 to 1:1, and (II) the weight ratio (i:ii) of the isocyanate component to the chlorine-containing component is 100:1 to 100:50, preferably 100:2.5 to 100:25, more preferably 100:5 to 100:15, most preferably 100:7.5 to 100:12.5.
[0015] Similarly, the preparation method of this microcapsule is unique because it requires the use of both the protein-based component and a combination of the two or more cross-linking agents as wall-forming materials. The microencapsulation method can be water-in-oil, oil-in-water, or water-in-oil-in-water: the latter is particularly useful when the core material is hydrophilic or water-soluble / dispersible and it is desirable to avoid the large amount of oil phase material required for water-in-oil methods. For convenience, the following description will use the oil-in-water method as an example; however, those skilled in the art will readily understand and recognize that this method is applicable to both water-in-oil and water-in-oil-in-water methods.
[0016] The first key component used in the production of the microcapsules of this teaching is the protein-based component. As previously noted, this component is selected from proteins, peptides, polypeptides, and combinations thereof. A common factor among all of these is that they have two binding sites for reacting with the cross-linking agent, or at least most, preferably at least 70 mol%, most preferably at least 80 mol%, and most preferably at least 90 mol%, of this component must have at least two binding sites for reacting with the cross-linking agent. The protein-based component is preferably a natural protein component, although synthetic equivalents may also be used. Both plant and animal proteins may be used; however, it is preferred that the protein component is derived from a plant. Exemplary animal protein-based components include animal proteins, animal polypeptides, animal peptides, egg proteins, silk proteins, milk proteins, gelatin, and combinations of one or more of the foregoing, particularly gelatin. Exemplary plant proteins include, but are not limited to, soy protein, pea protein, chickpea protein, common bean protein, lentil protein, potato protein, wheat protein, oat protein, malt protein, rye protein, barley protein, rice protein, algae protein, gluten protein, lupin protein, other legume proteins, and mixtures thereof. Regardless of the source of the protein-based components, they may be used or obtained in the form of concentrates, isolates, or combinations thereof. Such protein-based materials are commercially widely available and include food-grade, pharmaceutical-grade, and non-food-grade materials, depending on the end-use application of the resulting microcapsules. Given the lack of clear boundaries between proteins and peptides, and between peptides and polypeptides, the discussion herein will refer to both proteins and polypeptides; however, it should be understood that the discussion thereby encompasses all three, particularly where the context permits.
[0017] Generally, suitable proteins are those with a weight-average molecular weight of 5,000 Da to 110,000 Da, preferably 10,000 Da to 80,000 Da, more preferably 10,000 Da to 65,000 Da, and most preferably about 15,000 Da to about 40,000 Da. While proteins with a maximum weight-average molecular weight of up to 110,000 Da can be used, caution must be exercised because they, especially gelatin, tend to be sticky, particularly in the presence of moisture, which may adversely affect the intended end-use application. Of course, the properties can be adjusted by using two or more proteins with different weight-average molecular weights; however, in this case, it is preferable that the total weight-average molecular weight of the combination is adjusted to fall within the aforementioned preferred range.
[0018] Particularly preferred animal protein is gelatin, which is well-known and widely available, and is widely used in many industries for encapsulating substances such as food, pharmaceuticals, cosmetics, and agricultural products. Gelatin is typically prepared by partial acid hydrolysis (type A gelatin) or alkaline hydrolysis (type B gelatin) of natural collagen, which is found in animal collagen derived from skin, cartilage, bone, and tendons, particularly from fish, cattle, pigs, chickens, etc. The surface of gelatin carries a negative charge at higher pH levels and a positive charge at lower pH levels (pH 5). The isoelectric point of type A gelatin is in the range of 8-9, while that of type B gelatin is approximately pH 4.8 to 5.4. Gelatin used in this teaching also includes gelatin hydrolysates prepared by hydrolyzing gelatin with proteases such as collagenase and cysteine proteases. Suitable gelatin will typically have a Bloom value of 55 to 325. Typically, the weight-average molecular weight of the gelatin is determined according to the methods specified in "PAGI METHOD, Tenth edition" (Commission on Testing Method for Photographic Gelatin, 2006) for "20-1 Molecular weight distribution" and "20-2 Average molecular weight". Preferred gelatins are those that have undergone acid treatment, as such gelatin generally promotes or enables better control of particle size, especially if the goal is to control the particle size to the single-digit micrometer range. Similarly, from the perspective of gel network formation, the use of gelatin with relatively low gel strength is preferred. Specifically, the use of gelatin exhibiting a gel strength of 10 to 200 according to JISK 6503-2001 is preferred.
[0019] Particularly preferred plant proteins are those that are readily soluble or nearly readily soluble in water (or an aqueous phase), at least at the levels or concentrations used to prepare the microcapsules of this teaching. This teaching also applies to insoluble or poorly soluble plant proteins and / or isolates / fractions that have been fragmented to make them more soluble. Again, preferred plant proteins include, but are not limited to, soy protein, pea protein, chickpea protein, kidney bean protein, lentil protein, potato protein, wheat protein, oat protein, malt protein, rye protein, barley protein, rice protein, algae protein, gluten protein, lupin protein, other legume proteins, and mixtures thereof. These proteins may be in the form of protein concentrates, protein isolates, or combinations thereof, with or without fragmentation. Such proteins are commercially widely available and include food-grade, pharmaceutical-grade, and non-food-grade products, depending on the end-use application of the resulting microcapsules.
[0020] As described above, while the protein can be used as is, it is generally desirable to use a fragmented protein, thereby preparing a protein composition comprising protein fragments of various lengths (with a smaller overall median length) and various compositions. This is especially true for proteins that are insoluble or poorly soluble in water, particularly plant proteins. However, any known protein extract and / or isolate can undergo a fragmentation process, regardless of its water solubility: but it is particularly advantageous for those that are insoluble or poorly soluble in water. In this respect, even proteins that are not poorly soluble, i.e., those with a solubility less than 100% but greater than that of poorly soluble proteins, can also benefit from fragmentation, improving the overall solubility of the protein. For the purposes of this disclosure, a protein is considered insoluble if its solubility in water at room temperature and neutral pH is less than 25%; the solubility of poorly soluble proteins under these conditions is typically 25% to less than 70%. Again, while it is recognized that some protein isolates or fractions have different solubilities, particularly under different conditions; all such isolates and fractions can benefit from fragmentation, especially those fractions whose solubility parameters also fall within the aforementioned range. In the following text, the term fragmented protein refers to both fragmented extracts and fragmented isolates: the latter having undergone some form of fractionation.
[0021] The use of fragmented proteins generally allows for better control and / or manipulation of the final properties and performance characteristics of the resulting microcapsules. As mentioned above, fragmentation is particularly useful for proteins that are insoluble and / or difficult to disperse in the reaction phase they are added to due to their size and / or physical conformation, i.e., folded or unfolded: respectively, making and / or facilitating their use in microencapsulation methods. The fragmentation of said proteins can be achieved by any known method of breaking protein chains, whether or not said chains are unfolded first. Such methods include mechanical shearing, such as homogenization, sonication, pulverization, etc.; pH degradation; chemical degradation, such as saccharification, phosphorylation, acylation, etc.; high-temperature degradation; solvent degradation; salt degradation; and combinations thereof. Exemplary fragmentation methods are further described in Grossman, L et al., “Current insights into protein solubility: Areview of its importance for alternative proteins,” Food Hydrocolloids, 137 (2023) 108416, the contents of which are incorporated herein by reference. Preferably, said fragmentation method involves several of the foregoing parameters, more preferably one of which is mechanical shearing. Most preferably, the fragmentation process involves mechanical shearing and control / modification of pH and / or temperature within a specified fragmentation time period or duration. Generally, the resulting fragmented protein isolate typically comprises a protein fragment composition with a median particle size (i.e., D50) at least about 40%, more preferably at least about 50%, and most preferably at least about 60% smaller than the median particle size of the protein isolate before fragmentation. Preferred fragmented proteins have a median particle size of about 0.1% to about 60%, more preferably about 5% to about 35%, of the median particle size of the plant protein isolate before fragmentation. The final particle size and its distribution depend on the fragmentation method used and its duration, as well as the desired properties of the resulting microcapsules.
[0022] Suitable peptides for implementing this teaching are polypeptides having at least two sites that react with the crosslinking agent, and having an average molecular weight (Da) of less than 10,000, preferably 7,000 or less, most preferably 5,500 or less, and typically 2, preferably 5 to 100 amino acids. Preferred polypeptides comprise a straight chain of 5 to 50, preferably 15-45, most preferably 20-40 amino acids, typically but not limited to being bonded to each other by peptide bonds. Other bonds may be present in the straight chain, including disulfide bonds, sulfur bonds, urea bonds, etc.; however, such other bonds are few in number in each peptide chain, typically less than 20% of the bonds in the peptide chain, preferably less than 10%. As mentioned above, the reaction sites on the peptide are preferably primary amino reaction sites, but secondary amino and hydroxyl groups may also be present; most preferably all or substantially all of the reaction sites are primary amino reaction sites.
[0023] As described above, the peptides may be derived from natural resources or may be synthetic, particularly those formed via solid-phase peptide synthesis (SPPS) of amino acids. While the most common amino acids have an amino group and a carboxyl group on their α-carbon atom, this teaching is not limited to peptides of those amino acids, and it should be understood that peptides formed from amino acids in which the amino group is on the β or γ-carbon atom, and to a lesser extent, on the δ-carbon atom, are also considered and desired. Most particularly, the peptides are formed from α-amino acids and β-amino acids, and combinations thereof, with α-amino acids being the most particularly preferred. Furthermore, it should be appreciated that the amino acids are not limited to those having a single amino group and a single carboxyl group. Rather, suitable amino acids also have either or both of a plurality of amino and / or carboxyl groups, such as two amino groups and / or two carboxyl groups, as well as other reactive moieties / sites, including, for example, sulfur-containing groups or moieties present in or on their side chains: the latter providing disulfide bonds or sulfur bridges. Amino acids are well known, numbering in the hundreds, but this teaching is specifically directed to, but not limited to, peptides formed from more common and abundant amino acids, as described in more detail below and as will be understood by those skilled in the art.
[0024] While most natural peptides are derived from proteogenic amino acids (which may also contain low levels of non-proteogenic amino acids), synthetic peptides can be derived from proteogenic amino acids, non-proteogenic amino acids, and combinations of both, particularly, for example, those peptides containing both L-isomers and D-isomers of the same or different amino acids. Proteogenic amino acids are L-α-amino acids, including L-isomers of the following amino acids: arginine, histidine, lysine, aspartic acid, glutamic acid, serine, threonine, asparagine, glutamine, cysteine, selenocysteine, glycine, proline, alanine, isoleucine, leucine, methionine, phenylalanine, tryptophan, tyrosine, valine, and pyrrolidone. Non-proteinogenic amino acids include the D-isomers of the aforementioned amino acids, as well as, but not limited to, α-aminobutyric acid, valine, leucine, alloleucine, tert-leucine, α-aminoheptanoic acid, pipercoic acid, α,β-diaminopropionic acid, α,γ-diaminobutyric acid, ornithine, allothreonine, β-alanine, β-aminobutyric acid, α-aminoisobutyric acid, isovaleine, sarcosine, N-ethylglycine, N-propylglycine, N-isopropylglycine, N-methylalanine, N-ethylalanine, N-methyl-β-alanine, N-ethyl-β-alanine, isoserine, α-hydroxy-γ-aminobutyric acid, ornithine, phenylalanine, and β-aminobutyric acid. Of course, the peptide can also be formed from salts of the amino acids, particularly monohydrochlorides, including, for example, D-lysine monohydrochloride, L-lysine monohydrochloride, L-arginine monohydrochloride, D-arginine monohydrochloride, L-ornithine monohydrochloride, D-ornithine monohydrochloride, etc.
[0025] The peptides used to implement this teaching can also be formed from lower peptides, typically those having 10 or fewer amino acids, preferably 2-5 amino acids, particularly dipeptides, tripeptides, and tetrapeptides. Exemplary lower peptides include, but are not limited to, diamino acids such as dialanine, dilysine, diglycine, etc., and dipeptides having bonds other than peptide bonds, including, for example, cystine, cystathionine, ianothianine, quercetin, and diaminopimelic acid, etc.
[0026] The peptide can be a homopeptide, a conopeptide, or a combination thereof, wherein the homopeptide is composed of the same amino acids, and the conopeptide is composed of two or more different amino acids and / or lower peptides. The conopeptide includes peptides that simultaneously contain both L-isomers and D-isomers of the same amino acid. The conopeptide also includes peptides having multiple amino acids and / or diamino acids and / or lower peptides randomly linked along the peptide chain or in a structured arrangement, i.e., block peptides, wherein blocks of low to medium molecular weight peptides are bonded together to form a complete peptide, and the blocks can be homopeptides or conopeptides. Such block peptides can be random conopeptides, such as ABACBA, or structured, such as AAACCCBBAAA, the latter formed by known techniques, such as the sequential polymerization of the low to medium molecular weight peptide blocks, wherein A, B, and C represent low to medium molecular weight peptides, i.e., oligopeptides of 2 to 30 amino acids, preferably 3 to 20 amino acids, more preferably 5 to 10 amino acids.
[0027] Peptides in which one or both ends of the peptide chain are capped with selected amino acids are also considered. For example, it may be desirable to have amino or hydroxyl functional groups at or near the ends of the peptide chain. The former enables the formation of polyurea microcapsule walls, and the latter enables the formation of polyurethane microcapsule walls.
[0028] As described above, the protein-based component can be a single protein, polypeptide, or peptide; a combination of proteins (including fragmented proteins); a combination of polypeptides; a combination of peptides; and a combination of any of the foregoing. The specific protein-based component or mixture thereof chosen for any given microencapsulation depends on many factors, including desired physical properties, release properties, the specific microencapsulation method to be used, the phase to which the protein-based component will be introduced, and so on. The choice and / or composition, such as amino acids and their quantities, plays a significant role in the physical and release properties of the microcapsule wall. Similarly, the choice of the protein-based component and its percentage composition in the protein-based component also greatly influences its solubility / dispersibility in the phase introduced into the method and its affinity or repulsion to another phase. In this regard, it is well understood that some proteins, polypeptides, and peptides, especially their amino acid building blocks, have polar and / or charged side chains, hydrophobic side chains, etc. Therefore, by selecting specific proteins, polypeptides, and peptides and their combinations, especially their amino acid composition and concentration, the proteins, polypeptides, and peptides can be tailored to specific needs and methods. Of course, surfactants and other solubilizing / dispersing agents can also be used to assist in the solubilization and / or dispersion of the peptide in a selected phase. Suitable surfactants and solubilizing / dispersing agents include polyvinyl alcohol (PVA), polystyrene sulfonate (PSS), carboxymethyl cellulose (CMC), sodium salts of naphthalene sulfonate condensates, and mixtures thereof.
[0029] Although the foregoing discussion pertains to protein components having at least two reaction sites that react with the crosslinking agent, the use of such proteins having a single reaction site may also be considered, provided that the amount of such protein does not exceed about 30 mol% of the protein component, preferably not more than about 15 mol%, and more preferably not more than about 5 mol%. In cases where the crosslinking agent comprises a monofunctional crosslinking agent, it is preferable not to use or substantially not to use proteins having a single reaction site.
[0030] The second key component for forming the microcapsules of this teaching is the crosslinking component, which comprises a combination of two or more crosslinking agents, at least one of which is i) an isocyanate component selected from the group consisting of one or more diisocyanates and / or polyisocyanates, and at least one of the crosslinking agents is ii) a chlorine-containing component selected from the group consisting of a) diacyl chlorides and / or polyacyl chlorides, b) dichloroformates and / or polychloroformates and / or c) disulfonyl chlorides and / or polysulfonyl chlorides.
[0031] Suitable diisocyanates and polyisocyanates for implementing this teaching include those isocyanates known for forming polyurethanes, polyureas, and polyurethane-urea microcapsules, and are well known to those skilled in the art. These isocyanates include aliphatic, alicyclic, aromatic, polyaromatic, and other isocyanates and combinations thereof, and can exist as adducts, trimers, biurets, symmetrical trimers, asymmetrical trimers, oligomers, prepolymers, etc. Such isocyanates typically have 2 to 16, preferably 4 to 10, carbon atoms in the basic hydrocarbon skeleton. While diisocyanates are preferred, polyisocyanates are also desirable and useful, particularly those having 3 or 4 cyanate (NCO) groups, polyisocyanates having 3 to 10 cyanate groups in the case of dimers, biurets, trimers, oligomers, and prepolymers, and combinations of diisocyanates and polyisocyanates. While a single isocyanate is suitable, combinations of isocyanates are also desirable, such as combinations of diisocyanates and / or polyisocyanates, combinations of aliphatic and aromatic isocyanates, and combinations of both. In this regard, the weight percentage of each isocyanate can be 0-100% of the combination. In the case of combinations of aliphatic and aromatic isocyanates, preferably each is present in an amount of at least 5% by weight, preferably at least 10% by weight, more preferably at least 20% by weight, depending on the desired leakage rate. For example, aliphatic / aromatic isocyanate microcapsules with low leakage will typically have at least 50% by weight, more preferably at least 70% by weight of the aliphatic isocyanate. Furthermore, while a monoisocyanate may be present, it is not essential, and if present, it will constitute no more than 50 mol% of the isocyanate component, preferably no more than 30 mol%, more preferably no more than 20 mol%, and most preferably no more than 10 mol%. In cases where the protein-based component comprises monofunctional proteins, polypeptides, and / or peptides, it is particularly preferred that monoisocyanates are not used unless critical.
[0032] Exemplary aliphatic and alicyclic isocyanates include 2,2,4-trimethylhexamethylene diisocyanate, 2,4,4-trimethylhexamethylene diisocyanate, 1,4-butanediisocyanate, 1,6-hexamethylene diisocyanate (HDI), isophorone diisocyanate (IPDI), 4,4'-methylenebis(cyclohexane diisocyanate), cyclohexane-1,4-diisocyanate, and their adducts, trimers, biurets, symmetrical trimers, and asymmetrical trimers, particularly adducts, trimers, biurets, symmetrical trimers, and asymmetrical trimers of hexamethylene diisocyanate, including trimethylolpropane adducts of hexamethylene diisocyanate.
[0033] Aromatic isocyanates include m- and p-tetramethylphenyldimethyl diisocyanate (TMXDI), α,α'-phenyldimethyl diisocyanate, methylene diisocyanate (MDI), especially 4,4'-diphenylmethane diisocyanate, toluene diisocyanate (TDI), terephthalic diisocyanate, m-phenyl diisocyanate, 2,4,6-triisocyanatotoluene, 4,4',4'-triisocyanatotriphenylmethane, 1,2,4-phenyltriisocyanate, 2,5-norbornene diisocyanate, 3,3'-dimethyldiphenyl-4,4'-diisocyanate, naphthalene diisocyanate, and their adducts, trimers, biurets, symmetrical trimers, and asymmetric trimers, especially adducts, trimers, biurets, symmetrical trimers, and asymmetric trimers of toluene diisocyanate and diphenylmethane diisocyanate. Exemplary trimers include, but are not limited to, hexamethylene diisocyanate trimer and isophorone diisocyanate trimer, sold by Bayer Corporation of Pittsburgh, Pa under the trademark Desmodur.RTM.N-3390.
[0034] Suitable isocyanates also include oligomers and low molecular weight polymeric isocyanates, i.e., prepolymers: these are also materials well known to those skilled in the art. Preferably, to meet the requirement of degradability, such oligomers and low molecular weight polymeric isocyanates are formed from isocyanates with low molecular weight polyols, preferably C1 to C6 polyols, particularly diols and / or triols, most preferably linear diols and triols. Alternatively, or otherwise, consistent with the teachings of this specification, such oligomers and low molecular weight polymeric isocyanates can be prepared by reacting a single amino acid or a lower peptide of 2 to 5 amino acids with an isocyanate. In either case, in the preparation of such oligomers and low molecular weight polymers, an excess of said isocyanate is used to provide oligomers and low molecular weight polymers having at least two free cyanate groups. Exemplary oligomers and low molecular weight polymeric isocyanates include, but are not limited to, trimethylolpropane adducts of isocyanates, particularly trimethylolpropane adducts of toluene diisocyanate, diphenylmethane diisocyanate, and phenyl dimethyl diisocyanate.
[0035] In addition to the at least one isocyanate crosslinking agent, the microcapsules of this teaching also include at least one chlorine-containing component as a crosslinking agent, said chlorine-containing component being selected from a) diacyl chlorides and / or polyacyl chlorides, b) dichloroformates and / or polychloroformates and / or c) disulfonyl chlorides and / or polysulfonyl chlorides. In this respect, said chlorine-containing component can be a single crosslinking agent or a mixture of such crosslinking agents: the latter allows two or more crosslinking agents to come from the same family, i.e., (a) or (b) or (c), or one or more crosslinking agents from one family with one or more crosslinking agents from a second family or from all three families (a), (b) and (c).
[0036] Suitable acyl chlorides typically have the formula R 1 (C(O)Cl) x , where R 1 The acyl chloride is a hydrocarbon group having 3 to 12, preferably 3 to 10, more preferably 4 to 8 carbon atoms, and x is 2 to 4. The hydrocarbon group includes aliphatic and aromatic hydrocarbon groups. The former can be saturated or unsaturated (including polyunsaturated) straight-chain or branched hydrocarbon groups. The latter can include substituted aromatic groups, particularly those aromatic groups that are substituted with one or more low-carbon hydrocarbons in addition to the acyl chloride moiety. Most preferably, the acyl chloride is derived from a carboxylic acid, particularly a dicarboxylic acid, and most particularly saturated dicarboxylic acids. Exemplary acyl chlorides include adipoyl chloride, octanoyl dichloride, succinic acid chloride, azeloyl chloride, sebacoyl chloride, dodecanoyl dichloride, isophthaloyl chloride, terephthaloyl chloride, 1,3,5-benzenetricarboxylic acid chloride, and 1,2,4,5-benzenetetracarboxylic acid tetrachloride.
[0037] Suitable chloroformates include diethylene glycol chloride and those that typically have the formula R 2 Compounds of (OC(O)Cl)2, wherein R 2 It is a saturated straight-chain or branched hydrocarbon group having 2 to 10, preferably 2 to 6, more preferably 2 to 4 carbon atoms, or it is of formula -R 3 (OR 3 ) n - ether group, where R 3 It is a saturated straight-chain hydrocarbon group having 1 to 6, preferably 2 to 4, carbon atoms, and y is 1 to 8, preferably 1 to 6, more preferably 2 to 4. Most preferably, the chloroformate is derived from glycols and polyether glycols, particularly the glycols and polyethylene glycol. Exemplary chloroformates include ethylene bis(chloroformate), 1,4-butanediol bis(chloroformate), 1,6-hexanediol bis(chloroformate), ethylene glycol bis(chloroformate), tri(ethylene glycol) bis(chloroformate), diethylene glycol dichloroformate, neopentyl glycol bis(chloroformate), diethylene glycol chloride, 1,4-phenylene bis(chloroformate), bisphenol A bis(chloroformate), and bisphenol Z bis(chloroformate).
[0038] Suitable sulfonyl chlorides typically correspond to those with the formula R 4 Compounds of (SO2Cl)2, wherein R 4 The moiety is benzyl, biphenyl, naphthyl, diphenyl ether, or methylene diphenyl, and z is 2 to 4, preferably 2 to 3. In those cases where multiple aromatic rings (fused or linked) are present, each ring preferably has at least one sulfonyl chloride substituent. Exemplary sulfonyl chlorides include 1,3-benzene disulfonyl chloride, 1,4-benzene disulfonyl chloride, 1,3,5-benzene trisulfonyl chloride, 4,4'-biphenyl disulfonyl chloride, 4,4'-methylene bis(benzene sulfonyl chloride), 4,4'-bis(chlorosulfonyl) diphenyl ether, 1,5-naphthalene disulfonyl chloride, 4,4-naphthalene disulfonyl chloride, and 2,7-naphthalene disulfonyl chloride.
[0039] Furthermore, while monofunctional acyl chlorides, chloroformates, and sulfonyl chlorides may be present, they are not essential, and if present, they will constitute no more than 50 mol% of the isocyanate component, preferably no more than 30 mol%, more preferably no more than 20 mol%, and most preferably no more than 10 mol%. If the protein-based component comprises monofunctional proteins, polypeptides, and / or peptides, it is particularly preferred that monofunctional acyl chlorides, chloroformates, and / or sulfonyl chlorides are not used unless critical. Similarly, it is preferred that monoisocyanates and monofunctional acyl chlorides, chloroformates, and / or sulfonyl chlorides are not used together.
[0040] When preparing the microcapsules according to this teaching, the weight ratio (A:B) of the protein-based component (A) to the crosslinking component (B) is 100:1 to 1:100, preferably 50:1 to 1:50, more preferably 10:1 to 1:10, particularly 1:5 to 1:0.2, and most preferably 1:2 to 1:1. Furthermore, the weight ratio ((B)(i):(B)(ii)) of the isocyanate component (B)(i) to the chlorine-containing component (B)(ii) is 100:1 to 100:50, preferably 100:2.5 to 100:25, more preferably 100:5 to 100:15, and most preferably 100:7.5 to 100:12.5.
[0041] While the preparation of hollow, coreless microcapsules is known, this teaching is specifically directed to the preparation of microcapsules containing various core materials for their intended use. Core materials that can be encapsulated according to this teaching include a variety of substances, consistent with materials encapsulated using existing technologies and chemicals. Core materials include solid particles, semi-solid materials, hydrophilic liquids, lipophilic liquids, hydrophobic liquids, volatile liquids, etc. The specific choice depends on the intended use of the microcapsule. In fact, microcapsules have numerous applications across various industries and consumer goods sectors, including but not limited to agrochemicals, pharmaceuticals, cosmetics, personal care products, laundry detergents, home care and cleaning products, oral care, dental care, textiles, papermaking, mining, petroleum industry, water treatment, adhesives, coatings, plastics, sealants, construction, paints, inks, and dye formulations. Exemplary core materials include, but are not limited to, UV reflectors, UV absorbers, pigments, dyes, colorants, scale inhibitors, skin oils, pesticides, detergents, printing inks, preservatives and rust inhibitors, recording materials, inhibitors, antioxidants, pour point depressants, catalysts, initiators, waxes, deposition inhibitors, dispersants, flame retardants, biocides, reactive dye tracers, silicone conditioners, shampoos, biocides, adhesives, antifouling agents, deodorants, cosmetic additives, oxidants, personal care active ingredients, agrochemicals, fertilizers, fats, nutrients, enzymes, liquid crystals, natural oils, fragrances, flavorings and essential oils, crop protectants, pharmaceuticals, drugs, phase change materials, etc. Specific examples of the core material are disclosed in, for example, US 2013 / 0337023, US 10,456,766, US 8,119,214, US 9,714,397, US 10,485,739, US 4,977,060, US 10,675,277, US 20070138673 and US 20130302392, which are hereby incorporated herein by reference, as well as numerous other patents, patent publications, etc.
[0042] The following is a non-limiting list of exemplary core materials.
[0043] Straight-chain or branched hydrocarbons of different chain lengths and viscosities, such as mineral oil, petrolatum, white oil (also known as paraffin oil), dodecane, isododecane, squalane, hydrogenated polyisobutylene, polybutene, polydecene, docosane, hexadecane, isohexadecane, and other isoalkanes that belong to branched hydrocarbons.
[0044] Alcohols, diols, triols, or polyol esters of carboxylic acids or dicarboxylic acids or arylcarboxylic acids, whether naturally or synthetically derived, including: diisopropyl sebacate, diisopropyl adipate, isopropyl myristate, isopropyl palmitate, myristyl propionate, cetyl lactate, myristyl lactate, lauryl lactate, C12-15 alkyl lactates, dioctyl malate, decyl oleate, isodecanyl oleate, ethylene glycol distearate, ethylhexyl palmitate (octyl palmitate), isodecanyl neopentanoate, and so on. Tridecyl valerate, castor oil ester maleate, isostearyl neovalerate, di-2-ethylhexyl maleate, cetyl palmitate, myristyl myristate, stearyl stearate, cetyl stearate, isoctyl stearate, dioctyl maleate, octyl dodecyl stearate, isoctyl stearate, octyl dodecyl stearate, dioctyl sebacate, diisopropyl adipate, cetyl caprylate, glyceryl dilaurate, diisopropyl dilinoleate, and caprylic / capric triglycerides. Naturally derived substances include triglycerides, diglycerides, monoglycerides, long-chain wax esters, and mixtures thereof. Examples of naturally derived ester oils and waxes include, but are not limited to, argan oil, corn oil, castor oil, coconut oil, cottonseed oil, herring oil, avocado oil, beeswax, carnauba wax, cocoa butter, palm kernel oil, palm oil, peanut oil, shea butter, jojoba oil, soybean oil, rapeseed oil, flaxseed oil, rice bran oil, pine oil, sesame oil, sunflower oil, and safflower oil. Furthermore, hydrogenated, ethoxylated, propoxylated, and maleic acid-modified derivatives of the above substances are also useful, such as hydrogenated safflower oil and hydrogenated castor oil. Cholesterol and its esters and derivatives, as well as natural substances containing cholesterol derivatives, such as lanolin and lanolin oil, are also beneficial.
[0045] Phospholipids (such as lecithin), sphingomyelin, ceramides and related materials.
[0046] C4-C20 alkyl ethers of polypropylene glycol, C1-C20 carboxylic esters of polypropylene glycol, and di-C8-C30 alkyl ethers. Also includes PPG-14 butyl ether, PPG-15 stearyl ether, dioctyl ether, dodecyl octyl ether, and mixtures thereof.
[0047] Saturated and unsaturated fatty acids, including but not limited to oleic acid, palmitic acid, isostearic acid, stearic acid, ricinoleic acid, linoleic acid, and linolenic acid. Carbohydrates (monosaccharides, disaccharides, and polysaccharides) and related substances in the form of carboxylic acid monoesters and polyesters.
[0048] Polysiloxanes such as polyalkylsiloxanes, polydialkylsiloxanes, polydiarylsiloxanes, and polyalkylarylsiloxanes can also be used. This includes polydimethylsiloxane, commonly known as dimethyl silicone oil. Additionally, cyclic siloxanes (e.g., cyclopentane), polydimethylsiloxane alcohols, alkyl polymethylsiloxanes, alkyl polydimethylsiloxanes, polydimethylsiloxane copolyols, amino-functionalized siloxanes (e.g., amino polydimethylsiloxane, trimethylsiloxyamino polydimethylsiloxane), and amphoteric siloxanes (e.g., cetyl PEG / PPG-15 / 15 butyl ether polydimethylsiloxane, and bis-PEG-18 methyl ether dimethylsiloxane).
[0049] Oily and oil-soluble extracts of plant materials such as flowers and herbs. This includes a wide variety of materials, some non-limiting examples of which include extracts of rosemary, green tea, white tea or black tea, orchid, grape seed, sage, soybean, echinacea, arnica, rosehip, olive, and artichoke. It also includes other oil-soluble components extracted from plants, such as lycopene and other mixed carotenoids, capsaicin and capsaicinoids, polyphenols (such as rosmarinic acid), terpenes and terpenoid compounds, and oleoresins.
[0050] Exemplary dyes include, but are not limited to, Green 6 (CI 61570), Red 17 (CI 26100), Violet 2 (CI 60725), and Yellow 11 (CI 47000). Examples of oil-dispersible pigments include, but are not limited to, β-carotene (CI 40800), chromium hydroxide green (CI 77289), chromium oxide green (CI 77288), ferrous ferrocyanide (CI 77510), iron oxide (CI 77491, 77492, 77499), Pigment Blue 15 (CI 74160), Pigment Green 7 (CI 74260), Pigment Red 5 (CI 12490), Red 30 (CI 73360), titanium dioxide (CI 77891), and ultramarine (CI 77007).
[0051] Exemplary pharmaceutical active ingredients, particularly those used for the dermatological treatment of skin, hair, and nail conditions, include, but are not limited to, local anesthetics, antifungal agents, antibacterial agents, antiviral agents, antidandruff agents, antiacne agents, and anti-inflammatory agents (steroidal and nonsteroidal).
[0052] Examples of vitamins and their derivatives include tocopherol, tocopheryl acetate, retinol, retinyl palmitate, ascorbyl palmitate, nicotinamide, and beta-carotene.
[0053] Fragrances applicable to the practice of this teaching include, but are not limited to, any combination of perfumes, fragrances, essential oils, sensory stimulants, and plant extracts or mixtures thereof that can be packaged according to this application. Suitable lists of fragrances can be found in U.S. Patent Nos. 4,534,891, 5,112,688, 5,145,842, 6,194,375, 20110020416, and PCT applications WO2009153695 and WO2010 / 044834, and Perfumes Cosmetics and Soaps (2nd edition, 1959), edited by WA Poucher. All of the above documents are incorporated herein by reference in their entirety.
[0054] Typical representative flavor and sensory components include, but are not limited to, linalool, coumarin, geraniol, citral, limonene, citronellol, eugenol, cinnamal, cinnamyl alcohol, benzyl salicylate, menthol, menthyl lactate, eucalyptol, thymol, methyl salicylate, methyl furan, menthone, and cinnamaldehyde.
[0055] Typical examples of essential oils include, but are not limited to, orange, lavender, peppermint, lemon, pine, rosemary, rose, jasmine, tea tree, lemongrass, bergamot, basil, spearmint, juniper, clove, fennel, cumin, cypress, fir, black pepper, sandalwood, cedar, rosewood, cardamom, cinnamon, coriander, eucalyptus, geranium, ginger, chamomile, grapefruit, orange blossom, petitgrain, thyme, vetiver, and ylang-ylang.
[0056] Non-limiting examples of phase change materials include n-octacosane, n-heptacosane, n-hexacosane, n-pentacosane, n-tetracosane, n-trisane, n-didicosane, n-undecanane, n-eicosane, n-nonadecanane, n-octacosane, n-heptadecane, n-hexadecane, n-pentadecanane, n-tetradecane, and n-tetrazane.
[0057] Chemical and physical sunscreens / UV filters, such as 3-benzyl camphor, 4-methylbenzyl camphor, aminobenzoic acid (PABA), avobenzone, sulisobenzone-4, benzophenone-5, benzophenone-8, benzophenone-3, benzyl camphor sulfonic acid, and bis-ethylhexyloxyphenol methoxyphenyl triazine (Escalol) S), Butylmethoxydibenzoylmethane, Camphor benzalkonium chloride methyl sulfate, Sinoxazone, Diethylaminohydroxybenzoylhexyl benzoate, Dihydroxybenzoyl, Disodium phenyldibenzimidazole tetrasulfonate, Cresoltrazol trisiloxane, Ensolizol, Ethylhexyl dimethylaminobenzoate, Ethylhexyl methoxycinnamate, Ethylhexyl salicylate, Ethylhexyl triazine, Homosalate, Isoamyl p-methoxycinnamate, Melardine, Methyl anthranilate, Methylene bis-benzotriazolyl tetramethylbutylphenol / Bioctanetriazole (Tinosorb M), Octocrylene, Ethylhexyl methoxycinnamate, PEG-25 PABA, octyl salicylate, oxybenzone, pardimethicone O, phenylbenzimidazole sulfonic acid, polyacrylamide methyl benzyl camphor, polysiloxane-15, triethanolamine salicylate, terephthalamide dicamphor sulfonic acid, titanium dioxide, triethanolamine salicylate, and zinc oxide.
[0058] Hair treatment materials, in addition to those already covered in the aforementioned ingredient list, include cationic conditioning agents containing tertiary or quaternary amino groups (e.g., Quaternium-70, Quaternium-80, Stearamidopropyl Dimethylamine, Behenyltrimethylammonium Methyl Sulfate, Discocarboxydimethylammonium Chloride, Diceryldimethylammonium Chloride, Distearate Dimethylammonium Chloride, Hydroxyethyl Cetyldimethylammonium Phosphate). Furthermore, they include UV protectants and color protectants (e.g., DimethylPABAamidopropyl Lauryl Dimethylammonium Toluenesulfonate), heat protectants, and styling polymers (e.g., Vinylpyrrolidone and vinyl caprolactam derivatives, such as PVP vinyl caprolactam / DMAPA acrylate copolymer).
[0059] Consumer and agricultural chemical ingredients include pesticides and repellents, including N,N-diethyl-m-toluamide, IR3535, Icaridin, Picaridin, Saltidin, citronella, permethrin, neem oil, and lemon eucalyptus.
[0060] The core material also includes polymeric materials, particularly oil-soluble polymeric materials, which have film-forming properties on the skin and hair, such as VP / hexadecene copolymers, triacontyl PVP, and VP / eicosene copolymers, as well as cosmetic and personal care active ingredients for conditioning or beauty care of the skin, hair, or nails. These ingredients are listed in detail and generally covered in IP.com publications IPCOM000128968D (published September 23, 2005) and IPCOM000133874D (published February 13, 2006), the contents of which are hereby incorporated herein by reference.
[0061] The core material also includes corrosion inhibitors, which may be selected from the group consisting of: carboxylic acids and their derivatives, such as aliphatic fatty acid derivatives; imidazolines and their derivatives, including amides, quaternary ammonium salts, rosin derivatives, amines, pyridine compounds, trithionine compounds, heterocyclic sulfur compounds, quinoline compounds, or salts, quaternary ammonium salts, or polymers of any of the above substances, and mixtures thereof. Suitable corrosion inhibitors include, for example, primary, secondary, and tertiary amines; diamines; amides; polyethoxylated amines, diamines, or amides; salts of such substances; and amphoteric compounds. Other examples include imidazolines having straight-chain and branched alkyl chains, phosphate esters, and sulfur-containing compounds.
[0062] Similarly, the core material includes lipophilic scale inhibitors, including phosphate-based scale inhibitors and polyacrylates, and oxidants, including inorganic or organic peroxides, such as calcium peroxide, magnesium peroxide and lauroyl peroxide.
[0063] As mentioned above, using processing aids to facilitate microcapsule production can be beneficial, even if not essential. Two particularly advantageous aspects of processing aids are: dissolving or dispersing protein-based components in an aqueous phase, and dispersing or emulsifying an oil phase in an aqueous phase, or, where applicable, dispersing or emulsifying an aqueous phase in an oil phase. Generally, the use of such processing aids is most advantageous when the core material is difficult to grind, especially when it is difficult to obtain the target or desired particle / droplet size during emulsification. Preferred processing aids are emulsifiers and surfactants.
[0064] All types of emulsifiers are suitable for implementing this method, although it should be understood, and will be readily recognized by those skilled in the art, that different systems, such as different fragmented proteins, oil phases, and core materials, will be more suited to one or more classes of emulsifiers than other systems. Specifically, while this teaching generally applies to anionic, cationic, nonionic, and amphoteric emulsifiers, preferred emulsifiers are cationic and nonionic emulsifiers, particularly those containing polyalkylene ether units (especially polyethylene oxide units) with a degree of polymerization of the alkylene ether units greater than about 6. Preferred emulsifiers are those capable of significantly reducing the interfacial tension between the continuous aqueous phase and the dispersed oil phase composition, thereby reducing the tendency for droplet coalescence. In this regard, emulsifiers typically used in the aqueous phase to assist in the formation of oil-in-water emulsions or dispersions have HLB values between 11 and 17.
[0065] Cellulose derivatives, such as ethyl hydroxyethyl cellulose, 2-hydroxyethyl cellulose, hydroxybutyl methyl cellulose, hydroxypropyl methyl cellulose, etc.; gums, such as gum arabic and xanthan gum; poly(meth)acrylic acid and its derivatives; styrene-maleic acid copolymers and their derivatives; etc. Most preferably, the emulsifier / emulsion stabilizer is polyvinyl alcohol, especially polyvinyl alcohol derived from polyvinyl acetate, wherein 85% to 95%, preferably 88% to 90%, of the vinyl acetate groups have been hydrolyzed into vinyl alcohol units.
[0066] Other exemplary anionic surfactants and anionic surfactant classes suitable for implementing this teaching include: sulfonates; sulfates; sulfosuccinates; sarcosinates; alcohol sulfates; alcohol ether sulfates; alkyl aryl ether sulfates; alkyl aryl sulfonates, such as alkylbenzene sulfonates and alkylnaphthalene sulfonates and their salts; alkyl sulfonates; monophosphates or diphosphates of polyalkoxylated alkyl alcohols or alkylphenols; C 12 To C 15 Alkyl alcohols or polyalkoxylated C 12 To C 15Monosulfonated or disulfonated succinates of alkanols; ether carboxylates, especially alcohol ether carboxylates; phenolic ether carboxylates; polyesters of ethoxylated polyoxyethylene glycols composed of oxybutylene or tetrahydrofuran residues; sulfonyl alkylamides and their salts, such as sodium N-methyl-N-oleoyl taurate; polyoxyalkylene alkylphenol carboxylates; polyoxyalkylene alcohol carboxylates; alkyl polyglycoside / alkenyl succinic anhydride condensates; alkyl ester sulfates; naphthalene sulfonates; naphthaldehyde condensates; alkyl sulfonamides; sulfonated aliphatic polyesters; sulfates of styrene-phenylalkoxylates; sulfonates of styrene-phenylalkoxylates and their corresponding sodium, potassium, calcium, magnesium, zinc, ammonium, alkylammonium, and diethanolates. Ammonium salts or triethanolamine salts; lignin sulfonates, such as sodium, potassium, magnesium, calcium, or ammonium salts; polyarylphenol polyalkoxyether sulfates and polyarylphenol polyalkoxyether phosphates; and sulfated alkylphenol ethoxylates and phosphorylated alkylphenol ethoxylates; sodium lauryl sulfate; sodium laureth sulfate; ammonium lauryl sulfate; ammonium lauryl sulfate; sodium methylcocoyl taurate; sodium lauroyl sarcosinate; sodium cocoyl sarcosinate; potassium cocoyl hydrolyzed collagen; lauryl sulfate TEA (triethanolamine) salt; lauryl or cocoyl sarcosinate; disodium oleamide sulfosuccinate; disodium lauryl ether sulfosuccinate; sodium dioctyl sulfosuccinate; Sodium N-methyl-N-oleoyl taurate; Tristyrylphenol sulfate; Ethoxylated lignin sulfonate; Ethoxylated nonylphenol phosphate; Calcium alkylbenzene sulfonate; Ethoxylated tridecyl phosphate; Dialkyl sulfosuccinate; Perfluorinated (C6-C) 18 Alkylphosphonic acids; perfluorinated (C6-C4) 18 alkylphosphino acids; perfluorinated (C3-C4) 20Alkyl carboxylic acid esters; alkenyl succinic acid diglucamide; alkenyl succinic acid alkoxylates; sodium dialkyl sulfosuccinate; and alkenyl succinic acid alkyl polysaccharide glycosides. Further examples of suitable anionic emulsifiers include, but are not limited to, water-soluble salts of alkyl sulfates, alkyl ether sulfates, alkyl hydroxyethyl sulfonates, alkyl carboxylates, alkyl sulfosuccinates, alkyl succinamides, alkyl sulfates such as sodium dodecyl sulfate (SDS), alkyl sarcosinates, alkyl derivatives of protein hydrolysates, acyl aspartate salts, alkyl or alkyl ether or alkyl aryl ether phosphates, sodium dodecyl sulfate, phospholipids or lecithin, or soaps, sodium, potassium or ammonium salts of stearic acid, oleic acid or palmitic acid, alkyl aryl sulfonates such as sodium dodecylbenzene sulfonate, sodium dialkyl sulfosuccinate, dioctyl sulfosuccinate, sodium dilauryl sulfosuccinate, sodium polystyrene sulfonate, alkylene-maleic anhydride copolymers such as isobutylene-maleic anhydride copolymers or ethylene-maleic anhydride copolymers, etc. Lapis lager, sodium alginate, carboxymethyl cellulose, cellulose sulfate and pectin, polystyrene sulfonates, pectic acid, astragalus gum, almond gum and agar; semi-synthetic polymers such as carboxymethyl cellulose, sulfated cellulose, sulfated methyl cellulose, carboxymethyl starch, phosphorylated starch, lignin sulfonic acid; maleic anhydride copolymers (including their hydrolysis products), polyacrylic acid, polymethacrylic acid, acrylic acid-alkyl acrylate copolymers such as acrylic acid-butyl acrylate copolymers or crotonic acid homopolymers and copolymers, vinylbenzene sulfonic acid or 2-acrylamido-2-methylpropane sulfonic acid homopolymers and copolymers, and some amides or some esters of such polymers and copolymers, carboxyl-modified polyvinyl alcohol, sulfonic acid-modified polyvinyl alcohol and phosphoric acid-modified polyvinyl alcohol, phosphorylated or sulfated tristyrylphenol ethoxylates.
[0067] Exemplary amphoteric and cationic emulsifiers include: alkyl polysaccharides; betaine; sulfobetaine; glycine salts; C8 to C964 emulsifiers. 18 Alkylamides of fatty acids and C8 to C8 18 Fatty amine polyalkoxylates; C 10 To C 18 Alkyl dimethyl benzyl ammonium chloride; coconut oil alkyl dimethyl aminoacetic acid; C8 to C 18 Phosphate esters of fatty amine polyalkoxylated compounds; derived from starch or glucose syrup and fatty alcohols, particularly C8 to C8. 18 Alkyl polysaccharides (APGs) obtained from alcohols via an acid-catalyzed Fischer reaction, particularly those with a degree of polymerization of 1.3 to 1.6, especially 1.4 or 1.5, consisting of C8 to C4 groups. 10 and C 12 To C 14Alkyl polysaccharides. Other cationic emulsifiers include quaternary ammonium compounds with long-chain aliphatic groups, such as stearoyl dimethyl dichloride, and fatty amines. Cationic emulsifiers that may be mentioned also include alkyl dimethyl benzyl ammonium halide, alkyl dimethyl ethyl ammonium halide, etc. Specific cationic emulsifiers include palmitamide propyltrimethylammonium chloride, distearate dimethyl ammonium chloride, cetyltrimethylammonium chloride, and polyethyleneimine. Other amphoteric emulsifiers include alkylaminoalkane carboxylic acid betaine, sulfobetaine, imidazoline derivatives, sodium lauroyl amphoteric glycinate, sodium cocamidopropionate, and the amphoteric emulsifier cocamidopropyl betaine.
[0068] A suitable nonionic emulsifier is characterized by having at least one nonionic hydrophilic functional group. Preferred nonionic hydrophilic functional groups are alcohols, amides, and combinations thereof. Examples of nonionic emulsifiers include: monoglycerides and diglycerides; polyarylphenol polyethoxylates; polyalkylphenol polyethoxylates; polyethylene glycol ether derivatives of saturated fatty acids; polyethylene glycol ether derivatives of unsaturated fatty acids; polyethylene glycol ether derivatives of aliphatic alcohols; polyethylene glycol ether derivatives of alicyclic alcohols; fatty acid esters of polyoxyethylene dehydrated sorbitol esters; alkoxylated vegetable oils; alkoxylated acetylenic diols; polyalkoxylated alkylphenols; fatty acid alkoxylates; sorbitol alkoxylates; sorbitol esters; C8 to C8... 22 Alkyl or alkenyl polyglycosides; polyalkoxystyryl aryl ethers; amine oxides, particularly alkylamine oxides; block copolymer ethers; polyalkoxylated fatty glycerides; polyalkyl glycol ethers; linear aliphatic or aromatic polyesters; organosilicones; polyarylphenols; sorbitol ester alkoxylates; and monoesters and diesters of ethylene glycol and mixtures thereof; ethoxylated tristyrylphenols; ethoxylated fatty alcohols; ethoxylated lauryl alcohol; ethoxylated castor oil; and ethoxylated nonylphenol; alkoxylated alcohols, amines, or acids; fatty acid amides, such as stearamide, laurylamide diethanolamide, and laurylamide monoethanolamide; long-chain fatty alcohols, such as cetyl alcohol and stearyl alcohol; glycerides, such as glyceryl laurate; polyoxyalkylene glycols and alkyl and aryl ethers of polyoxyalkylene glycols, such as polyoxyethylene glycerol nonylphenyl ether and polypropylene glycol stearate. Polyethylene glycol oligomers and alkyl or aryl ethers or esters of oligomeric polyethylene glycols are preferred. In addition, polyvinyl alcohol, polyvinyl acetate, copolymers of polyvinyl alcohol and polyvinyl acetate, carboxylated or partially hydrolyzed polyvinyl alcohol, methylcellulose, various latex materials, stearates, lecithin, and various surfactants are also preferred as nonionic emulsifiers. It is well known that polyvinyl alcohol is typically prepared by partial or complete hydrolysis of polyvinyl acetate. Therefore, when referring to polyvinyl alcohol, this disclosure intends to cover both completely hydrolyzed and partially hydrolyzed polyvinyl acetate. Regarding the latter, a degree of hydrolysis of the polyvinyl acetate is preferably at least 50 mol%, more preferably at least 75 mol%.
[0069] When the emulsifier is a polymeric emulsifier, particularly one containing acrylates or derived from acrylates (e.g., polyacrylates), its molecular weight is typically at least 10,000, preferably at least 20,000, and most preferably 30,000 or higher. Furthermore, the amount of emulsifier used is typically from about 0.1% to about 40% of the total weight of the formulation, more preferably from about 0.2% to about 15% of the total weight, and most preferably from about 0.5% to about 10% of the total weight. It should be understood that certain acrylic polymers and copolymers can act as emulsifiers or as polymerizable and / or non-polymerizable components in the formation of microcapsule walls. In the latter case, polymeric emulsifiers, especially high molecular weight polymers, can be trapped and / or incorporated into the polymer wall during its formation. This is particularly likely to occur when the properties of the aqueous phase change and dissolved polymers precipitate.
[0070] While not strictly necessary, the use of other stabilizers may be desired, which can be used alone or in combination with the aforementioned materials, including ionic monomers. Typical cationic monomers include dialkylaminoalkyl acrylates or methacrylates, including quaternary ammonium salts or acid addition salts, and dialkylaminoalkylacrylamides or methacrylamides, including quaternary ammonium salts or acid addition salts. Typical anionic monomers include olefinically unsaturated carboxylic acids or sulfonic acid monomers, such as acrylic acid, methacrylic acid, itaconic acid, allyl sulfonic acid, vinyl sulfonic acid, especially their alkali metal salts or ammonium salts. Particularly preferred anionic monomers are olefinically unsaturated sulfonic acids and their salts, especially 2-acrylamido-2-methylpropanesulfonic acid and its salts.
[0071] Similarly, although not essential, the aqueous and core phase components may further contain other components commonly found in the art, including, for example, chain transfer agents and / or agents that help control the molecular weight / degree of polymerization of the wall-forming monomers, thereby promoting the movement of oligomers / prepolymers in the respective oil and aqueous phase components. Suitable chain transfer agents include, but are not limited to, lower alkyl alcohols containing 1 to 5 carbon atoms, mercaptoethanol, mercaptopropanol, mercaptoacetic acid, isooctyl mercaptopropionate, tert-nonylthiol, pentaerythritol tetra(3-mercaptopropionate), dodecyl mercaptothiol, formic acid, halogenated hydrocarbons (such as bromoethane, bromotrichloromethane, or carbon tetrachloride), and sulfates, bisulfates, hydrosulfates, phosphates, hydrogen phosphates, dihydrogen phosphates, toluenesulfonates, and benzoates of sodium and potassium, particularly sodium hypophosphite and sodium bisulfate. If a chain transfer agent is used, its amount is preferably 0.01% to 5% by weight of the wall-forming monomers and / or oligomers used, more preferably 0.5% to 3%.
[0072] Continuing from the foregoing, the wall-forming composition may also include various polyfunctional amines and alcohols that can be dispersed or dissolved in water or aqueous solutions and can react with the isocyanate and / or the chlorinated crosslinking agent, such as chloroformate, particularly the isocyanate, as supplementary crosslinking agents for modifying the physical properties of the microcapsule wall. Specifically, preferred supplementary crosslinking agents can be used to regulate or control release characteristics while having minimal or moderate impact on degradability. Such crosslinking agents are well known in the art and typically have two or more (preferably 2 to 5) primary or secondary amine groups or hydroxyl groups, or combinations of hydroxyl and amine groups, including, for example, aldehydes and their derivatives, epoxy resins and their derivatives, isocyanates and their derivatives, etc. Typically, they can be monomeric compounds, dimers, oligomers, or low molecular weight polymers. In particular, they tend to have low molecular weights, typically 500 or less, preferably 250 or less. Exemplary amines include 1,2-ethylenediamine, 1,3-diaminopropane, 1,4-diaminobutane, 1,6-diaminohexane, hydrazine, 1,4-diaminocyclohexane, 1,3-diamino-1-methylpropane, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, bis(2-methylaminoethyl)methylamine, triethanolamine, bis(dimethylaminoethyl) ether, triisopropanolamine, ethanolamine, guanidineamine, and their derivatives. Exemplary polyols include ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, triethylene glycol, 2-ethyl-1,3-hexanediol, glycerol, 1,2,6-hexanetriol, trimethylolpropane, trimethylolethane, and tri(hydroxyphenyl)propane. If used, the amount of these supplementary crosslinking agents is preferably 0.01% to 20% by weight of the wall-forming monomers and / or oligomers used, more preferably 0.5% to 10%. These crosslinking agents can be added to the aqueous phase before emulsion formation or after emulsion formation.
[0073] The particle size of the microcapsules described in this teaching varies considerably, depending on the core material, the intended end use, and limitations of the method used to form the microcapsules, particularly the core material dispersion / emulsion. Typically, the volume-weighted median particle size ranges from about 2 micrometers to about 200 micrometers, preferably from about 5 micrometers to about 50 micrometers, and most preferably from about 10 micrometers to about 20 micrometers. Suitable equipment for performing such measurements is widely available, including, for example, the Accusizer 780A manufactured by Particle Sizing Systems, Santa Barbara, California.
[0074] In the following text, the thickness of the microcapsule wall also depends on the intended end use of the microcapsule, as well as the wall material itself, the concentration level of the microcapsule wall, and its physical properties / desired physical properties. The wall thickness is typically controlled by the amount of wall material used in the encapsulation process and the size / number of the dispersed phase microspheres to be encapsulated. Generally, the wall material accounts for 3% to 30% of the total weight of the microcapsule forming material, i.e., the wall material and the core material, preferably 5% to 20%, more preferably 8% to 15%.
[0075] Microencapsulation of the core material using the encapsulation wall forming material described above can be achieved by any known microencapsulation method. Suitable techniques include agglomeration, interfacial polymerization, air suspension, centrifugal extrusion, spray drying, disc coating, in-situ polymerization, and methods by forming a dispersion of the core and shell material and applying a pressure shock wave to the dispersion, as described in Redding Jr. (US 5,271,881, incorporated herein by reference). The specific method and material selection depend on the properties of the material to be encapsulated, including its physical and / or chemical properties, such as whether the carrier material is in a liquid, solid, semi-solid, or gel-like particulate state.Exemplary methods are described below and in the following patents, such as those by Schwantes (US 6,592,990), Nagai et al. (US 4,708,924), Baker et al. (US 4,166,152), Wojciak (US 4,093,556), Matsukawa et al. (US 3,965,033), Matsukawa (US 3,660,304), Ozono (US 4,588,639), Irgarashi et al. (US 4,610,927), Brown et al. (US 4,552,811), Scher (US 4,285,720), Shioi et al. (US 4,601,863), Kiritani et al. (US 3,886,085), and Jahns et al. (US 4,886,085). 5,596,051 and 5,292,835), Matson (US 3,516,941), Chao (US 6,375,872), Foris et al. (US 4,001,140; 4,087,376; 4,089,802 and 4,100,103), Greene et al. (US 2,800,458 and 2,730,456), Clark (US 6,531,156), Saeki et al. (US 4,251,386 and 4,356,109), Hoshi et al. (US 4,221,710), Hayford (US 4,444,699), Hasler et al. (US 5,105,823), Stevens (US 4,197,346), Riecke (US The following sources are incorporated herein by reference: Greiner et al. (US 4,547,429) and Tice et al. (US 5,407,609), Herbig in the chapter entitled “Encapsulation” in Kirk Othmer, Encyclopedia of Chemical Technology (Vol. 13, 2nd edition, pp. 436-456), Huber et al. in “Capsular Adhesives” in Tappi (Vol. 49, No. 5, pp. 41A-44A, May 1966).
[0076] Generally, the first step of the encapsulation process is to prepare discrete particles, domains, droplets, or microspheres of the core material, with or without one of the wall-forming components and / or processing aids (e.g., emulsifiers), depending on the specific core material and the method to be used, such as oil-in-water, water-in-oil, or water-in-oil-in-water. Typically, the core material is dissolved, solubilized, dispersed, suspended, or emulsified within one of the wall-forming materials, which serves as a phase in the microencapsulation process, alone and / or together with another solvent, carrier, or processing aid. When such materials are in solution or liquid form and the encapsulation will be carried out by, for example, coagulation, interfacial polymerization, the solution or liquid containing the core material is subjected to high-shear mixing or agitation to produce a suspension, emulsion, or colloidal system of discrete domains of the core material of the desired size. When the core material is a heat-sensitive material, such as wax or a waxy material, the carrier and the core material contained therein are heated above its melting temperature and then subjected to similar high-shear mixing or stirring in a liquid medium (preferably one of the wall material or phase material, such as an aqueous phase or an oil phase) to form discrete droplets of the core material. This is followed by cooling to allow solid particle formation, and then encapsulation. When the core material is solid or substantially solid, it can be ground and sorted to the desired particle size prior to encapsulation. Such methods, as well as other alternative methods for preparing particles or discrete domain regions for encapsulation, are widely used in industry and are well known to those skilled in the art.
[0077] Although not limited thereto, the microcapsules described in this teaching are preferably prepared by interfacial polymerization. In this process, the core material is dissolved, dispersed, or emulsified in a liquid solution of a material used as / containing one of the wall materials, preferably an oil phase containing isocyanates; or, in the case of a water-in-oil-in-water system, the core material is dispersed or emulsified in a first aqueous phase, which preferably does not contain wall materials, and then the aqueous phase containing the core material is dispersed or emulsified in an oil phase, which is further dispersed or emulsified in a second aqueous phase, which ultimately becomes the continuous phase of the interfacial polymerization and contains other wall materials, namely peptides and / or proteins.
[0078] As stated above, microcapsules prepared according to this teaching have numerous commercial and consumer applications in almost all industries and in many commercial products.
[0079] In one embodiment, the microcapsules described herein can be incorporated into personal care products and compositions, including but not limited to cosmetics, drug delivery systems, hair care products, skin care products and oils, pharmaceuticals, pigment dispersions, preservative compositions, skin coloring products, skin repair products, hair styling products, sunscreens and tanning lotions, sprays, oils, creams, etc., waterproof and moisture-proof products, abrasion-resistant products and additives, shower gels, shampoos, and heat-protective / heat-enhancing compositions. Dental personal care compositions include denture adhesives, toothpaste, mouthwash, chewing gum, etc.
[0080] The microcapsules can be used in a variety of pharmaceutical applications and compositions, including oral and topical dosage forms such as tablets, pellets, capsules, dermatological products (creams, gels, ointments, sprays, lotions, and foams), transdermal patches, etc.
[0081] The microcapsules can also be used in combination with a variety of agrochemicals, particularly the many agrochemicals listed in U.S. Patent No. 5,389,688 to ISP, which is incorporated herein by reference in its entirety.
[0082] In common consumer products, the microcapsules can be used to incorporate active ingredients such as fabric softeners, liquid laundry detergents, powder laundry detergents, dishwashing detergents, hard surface cleaners, antistatic agents, deodorants, antibacterial agents, etc., into various household cleaners and other "cleaning" products such as air fresheners and sprays, as well as to be applied to textiles, paper, etc., as surface modifiers or coatings.
[0083] The microcapsules described in this teaching can be advantageously used to control fragrance release in aromatic consumer products. Using the microcapsules described in this teaching, the lifespan and intensity of the encapsulated fragrance are significantly improved in practical use. Examples of consumer products containing fragrance microcapsules according to certain aspects of this application fall into the product group categories of laundry detergents, cosmetics, personal care products, dishwashing liquids, and house cleaners. More specific examples of consumer products include fabric conditioners, liquid / powder detergents, dishwashing liquids, shampoos, conditioners, hair styling gels, soaps, shower gels, body gels, multi-purpose cleaners including hard surface cleaners, carpet cleaners, body washes, antiperspirants / deodorants, and sprayable products.
[0084] In another embodiment of this teaching, a method for producing fragrance-loaded microcapsules with enhanced affinity is provided for incorporation into (i) laundry detergents; (ii) fabric softener compositions; and (iii) fabric softener products with added dryers. Such microcapsules are deposited on fabrics during washing, remain on the fabric surface after initial application, and can be sheared upon subsequent mechanical application. Thus, the encapsulated fragrance provides a “burst release” of fragrance during wear and / or cleaning due to capsule wall rupture.
[0085] Alternatively, the fragrance microcapsules of this application may be formulated into solid fabric care compositions with polysaccharides, such as sugars, according to the method described in U.S. Patent No. 2011 / 0082066, the contents of which are hereby incorporated by reference. The solid fabric care products may be used to deliver fragrance to textiles during a wash / clean cycle, subsequently washing the textiles to provide a beneficial fragrance character during wear.
[0086] Alternatively, the fragrance microcapsules may be incorporated into two-in-one powdered detergent and conditioner compositions as described in US 4,698,167 and 5,540,850; and into crystalline laundry detergent additives as described in US Applications 2011 / 97369 and PCT WO 2010 / 000558, which are incorporated herein by reference.
[0087] For some embodiments, it may be preferable to incorporate multiple core materials into a single microcapsule and / or provide a mixture of such microcapsules. For example, in addition to the respective active substances, one or more preservatives and / or antimicrobial agents may be added to the delivery matrix, including but not limited to benzoic acid, sorbic acid, dehydroacetic acid, piroctone olamine salt, DMDM hydantoin, IPBC, triclosan, bromonitrobenzene, isothiazolinone, p-hydroxybenzoate, phenoxyethanol, and combinations thereof.
[0088] In another embodiment, the core material can be a phase change material or a mixture thereof for temperature control. Typical phase change materials have melting temperatures ranging from -20°C to 100°C and typically contain straight-chain or branched hydrocarbons, fatty acid esters, or mixtures thereof with varying chain lengths and melting points. Microcapsules containing the phase change material core material can be coated, sprayed, or incorporated into suitable materials such as textile fibers like cotton and polyester during the textile process, or directly coated onto textiles, or incorporated into building materials such as bricks, plaster, etc., thereby utilizing latent heat of fusion to allow for temperature control.
[0089] Furthermore, the microcapsules described in this teaching can be used in the construction industry with cement, gypsum board, hollow blocks, particleboard, heat transfer fluids, sealants, adhesives, etc. In this case, the core material can be a phase change material, biocide, flame retardant, catalyst, epoxy resin, etc.
[0090] This microcapsule also has many automotive applications, including the use of encapsulated phase change materials in cooling systems, the use of encapsulated lubricant additives such as anti-wear additives in engine oils, and the use of encapsulated UV absorbers and / or corrosion inhibitors in automotive coatings.
[0091] The microcapsules described herein can also be used with additives for plastics, such as flame retardants, catalysts, pigments, light stabilizers, UV absorbers, etc., all of which can be encapsulated to allow for greater compatibility, lifespan, and self-healing capabilities in plastic materials. For example, the core material can be a catalyst for self-healing, a UV absorber for protection against UV light damage, or a thermochromic material for changing the color of coatings across a wide range of industries.
[0092] The microcapsules described in this teaching can also be used in oilfield applications. These microcapsules may contain conventional oilfield chemicals, such as corrosion inhibitors, scale inhibitors, oxidants, crosslinking agents, catalysts, acidifiers, biocides, demulsifiers, enzymes, polymers, lubricants, shale inhibitors, solvents, and surfactants. Encapsulated oilfield chemicals can be advantageously applied at various stages of oil extraction, from drilling, cementing, and enhancement to production and improved oil recovery. The release mechanism of oilfield chemical delivery can be influenced by temperature, dilution, pH, and shear stress at the application-related stages.
[0093] Example Numerous microcapsules have been formed according to this teaching, and numerous comparative microcapsules have also been formed using materials outside the limitations described herein. Typically, the microcapsules are formed using a water-insoluble core material according to the following steps: • At ambient temperature, the protein-based components are dissolved in deionized water by stirring in a stainless steel reaction vessel equipped with mixing blades, with or without emulsifiers, to prepare an aqueous solution. Once the mixture is prepared, the mixing blades are replaced with grinding blades.
[0094] • At ambient temperature, in another container, the core material to be encapsulated is mixed with one or more crosslinking components using a mixing paddle to prepare an oil phase solution.
[0095] Then, at a predetermined temperature, the oil phase solution is gradually added to the aqueous phase solution under high-shear milling to form an oil-in-water emulsion, and the high-shear milling continues until the target emulsion droplet size is reached.
[0096] Once the target droplet size is reached, grinding is paused, and the grinding blades are replaced with mixing blades, which are then activated to continuously agitate the mixture and maintain the emulsion.
[0097] • Thereafter, the temperature of the reaction vessel is raised to 50°C within 60 minutes and maintained at that temperature for another 60 minutes.
[0098] • Subsequently, the temperature of the reaction vessel is raised to 65°C within 60 minutes and maintained at that temperature for another 120 minutes.
[0099] • Subsequently, the temperature of the reaction vessel is raised to 85°C over a period of 60 minutes and maintained at that temperature for another 6 hours, at which point the reaction is considered complete.
[0100] At the end of the reaction, the resulting microcapsule slurry was cooled to ambient temperature in the reaction vessel. The slurry was found to be low in viscosity and generally homogeneous and smooth, with no visible thickening and / or agglomeration. The microcapsules were then recovered from the slurry for testing.
[0101] While the preparation and grinding of the solutions and mixtures are preferably carried out at room temperature, it should be understood that slightly elevated temperatures may be desirable to facilitate faster and easier formation of the solutions and / or emulsions. Furthermore, the grinding temperature and / or heating rate during wall formation can be varied depending on the reactivity and quantity of the raw materials used. In this regard, it should be understood that if excessively high grinding temperatures and / or excessively rapid heating rates are used, the capsule slurry may gel during heating and / or wall formation, or the emulsion may coalesce. In this respect, if the raw materials are highly reactive, grinding at room temperature is preferred. On the other hand, if the raw materials are less reactive, a higher grinding temperature is preferred.
[0102] The release of the core material fragrance oil from the obtained microcapsules was evaluated in hexane release / extraction and in two traditional end products suitable for this type of microcapsule: heavy-duty liquid laundry detergent (HDL) from Seventh Generation, Inc., and liquid fabric strengthener (LFE); the former is fragrance-free Downy® fabric softener. All tests were performed in duplicate or triplicate.
[0103] Release of fragrance oils from hexane This method is based on the CIPAC MT190. The capsule slurry is placed in a 110 ml container. Hexane containing an internal standard (dicyclohexyl phthalate) is added to the container. The container is placed on a horizontal roller and rotated at 70 rpm. At precise intervals of 15, 30, 60, and 180 minutes, 1 ml of solution sample is precisely extracted and placed into a vial. The vial is analyzed by GC-FID to determine the target core component.
[0104] Release of fragrance oil RA from liquid matrix The release properties of the microcapsules, specifically the release of the fragrance, were evaluated. Evaluations were conducted in a heavy-duty liquid laundry detergent (HDL) from Seventh Generation, Inc., and in a commercial liquid fabric strengthener (LFE—fragrance-free Downy). ®The process involves using a fabric softener (LFE or HDL). Weigh the LFE or HDL sample into a 50 ml glass jar. Add the specified amount of capsule slurry and mix thoroughly. After mixing, seal the jar tightly and place it in an oven at 35°C for one week. After one week, remove the sample from the oven. Aliquot the sample from the jar and place it in a scintillation bottle. Add a small amount of water and mix gently, ensuring no foaming occurs. Add hexane to extract the core material through gentle mixing for analysis. Allow the solution to stand and separate, then sample the hexane layer for GC-FID analysis.
[0105] Example 1 (Comparative Example) Microcapsules were formed according to the aforementioned method. Specifically, in a 1-liter stainless steel reactor, 13.6 g of soybean protein isolate from MPBiomaterials, LLC. was dissolved in 217 g of deionized water to prepare an aqueous solution. At ambient temperature, 81.4 g of the flavor blend Research Accord (RA) and 81.4 g of Captex from ABITEC Corporation were mixed in a beaker. ® 355g of caprylic / capric triglycerides (fragrance diluent) were mixed to prepare a capsule core composition. The fragrance blend contained common odor compounds, including benzyl acetate, isobornyl acetate, and hexyl salicylate. Subsequently, 6.78g of Mondur from Covestro LLC was added under stirring. ® MR Light isocyanate (polymeric MDI (diphenylmethane diisocyanate)) is added to the beaker until thoroughly mixed to form an oil phase composition. The oil phase composition is then gradually added to a reactor containing the aqueous phase composition under high-shear milling, and this high-shear milling is maintained until a target emulsion droplet size of approximately 10 micrometers is achieved. Once the target emulsion droplet size is reached, milling is paused, the milling blades are replaced with mixing blades to maintain emulsion mixing, and the mixture undergoes the aforementioned heating reaction step to form the microcapsules.
[0106] Example 2 The microcapsule slurry was prepared according to the method of Example 1, except that 6.44 g of Mondur was used. ® MR Light isocyanate and 0.34 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0107] Example 3 The microcapsule slurry was prepared according to the method of Example 1, except that 6.1 g of Mondur was used. ®MR Light isocyanate and 0.68 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0108] Example 4 The microcapsule slurry was prepared according to the method of Example 1, except that 5.42 g of Mondur was used. ® MRLightt isocyanate and 1.36 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0109] Example 5 The microcapsule slurry was prepared according to the method of Example 1, except that 6.44 g of Mondur was used. ® MR Light isocyanate and 0.34 g of adipicoyl chloride from TCI America were used as the crosslinking components.
[0110] Example 6 The microcapsule slurry was prepared according to the method of Example 1, except that 6.1 g of Mondur was used. ® MR Light isocyanate and 0.68 g of adipicoyl chloride from TCI America were used as the crosslinking components.
[0111] Example 7 The microcapsule slurry was prepared according to the method of Example 1, except that 5.42 g of Mondur was used. ® MR Light isocyanate and 1.36 g of adipicoyl chloride from TCI America were used as the crosslinking components.
[0112] Example 8 The microcapsule slurry was prepared according to the method of Example 1, except that 6.44 g of Mondur was used. ® MR Light isocyanate and 0.34 g of tri(ethylene glycol) bis(chloroformate) from Sigma Aldrich were used as the crosslinking components.
[0113] Example 9 The microcapsule slurry was prepared according to the method of Example 1, except that 6.1 g of Mondur was used. ® MR Light isocyanate and 0.68 g of tri(ethylene glycol) bis(chloroformate) from Sigma Aldrich were used as the crosslinking components.
[0114] Example 10 The microcapsule slurry was prepared according to the method of Example 1, except that 5.42 g of Mondur was used. ®MR Light isocyanate and 1.36 g of tri(ethylene glycol) bis(chloroformate) from Sigma Aldrich were used as the crosslinking components.
[0115] Example 11 The microcapsule slurry was prepared according to the method of Example 1, except that 6.44 g of Mondur was used. ® MR Light isocyanate and 0.34 g of bisphenol A bis(chloroformate) from Sigma Aldrich were used as the crosslinking components.
[0116] Example 12 The microcapsule slurry was prepared according to the method of Example 1, except that 6.1 g of Mondur was used. ® MR Light isocyanate and 0.68 g of bisphenol A bis(chloroformate) from Sigma Aldrich were used as the crosslinking components.
[0117] Example 13 The microcapsule slurry was prepared according to the method of Example 1, except that 5.42 g of Mondur was used. ® MR Light isocyanate and 1.36 g of bisphenol A bis(chloroformate) from Sigma Aldrich were used as the crosslinking components.
[0118] Example 14 The microcapsule slurry was prepared according to the method of Example 1, except that 6.44 g of Mondur was used. ® MR Light isocyanate and 0.34 g of 1,3-benzenedisulfonyl chloride from TCI America were used as the crosslinking components.
[0119] Example 15 The microcapsule slurry was prepared according to the method of Example 1, except that 6.1 g of Mondur was used. ® MR Light isocyanate and 0.68 g of 1,3-benzenedisulfonyl chloride from TCI America were used as the crosslinking components.
[0120] Example 16 The microcapsule slurry was prepared according to the method of Example 1, except that 5.42 g of Mondur was used. ® MR Light isocyanate and 1.36 g of 1,3-benzenedisulfonyl chloride from TCI America were used as the crosslinking components.
[0121] Example 17 The microcapsule slurry was prepared according to the method of Example 1, except that 6.78 g of Takenate D-110N isocyanate (phenylene diisocyanate adduct polymer) from Mitsui Chemicals, Inc. was used as the crosslinking component.
[0122] Example 18 The microcapsule slurry was prepared according to the method of Example 17, except that 6.44 g of Takenate D-110N isocyanate and 0.34 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0123] Example 19 The microcapsule slurry was prepared according to the method of Example 17, except that 6.1 g of Takenate D-110N isocyanate and 0.68 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0124] Example 20 The microcapsule slurry was prepared according to the method of Example 17, except that 5.42 g of Takenate D-110N isocyanate and 1.36 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0125] Table 1 summarizes the formulations of the microcapsules prepared using the two crosslinking agents in each of the above groups, as well as the fragrance release of the capsules in hexane and in HDL and LFE matrices.
[0126] Table 1
[0127] Example 21 (Comparative Example) Microcapsules were formed according to the following process. An aqueous solution was prepared in a 1-liter stainless steel reactor by dissolving 13.6 g of gelatin from Ajinomoto North America, Inc. in 217 g of deionized water. At ambient temperature, 138 g of the fragrance blend Research Accord (RA) and 24 g of Captex from ABITEC Corporation were mixed in a beaker. ®Capsule core compositions were prepared by mixing 355 caprylic / capric triglycerides (fragrance diluents) with a blend of common odor compounds, including benzyl acetate, isobornyl acetate, and hexyl salicylate. Subsequently, 6.78 g of Takenate D110N isocyanate (phenylene diisocyanate adduct polymer) from Mitsui Chemicals, Inc. was added to the beaker under stirring until fully mixed to form the oil phase composition. The oil phase composition was then gradually added to a reactor containing the aqueous phase composition under high-shear milling, and the high-shear milling was maintained until a target emulsion droplet size of approximately 10 micrometers was achieved. Once the target emulsion droplet size was reached, milling was paused, the mill blades were replaced with mixing paddles to maintain emulsion mixing, and the mixture was subjected to the above-described heating reaction step to form microcapsules.
[0128] Example 22 The microcapsule slurry was prepared according to the method of Example 21, except that 6.44 g of Takenate D-110N isocyanate and 0.34 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0129] Example 23 The microcapsule slurry was prepared according to the method of Example 21, except that 6.1 g of Takenate D-110N isocyanate and 0.68 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0130] Example 24 The microcapsule slurry was prepared according to the method of Example 21, except that 5.42 g of Takenate D-110N isocyanate and 1.36 g of sebacyl chloride from Sigma Aldrich were used as the crosslinking components.
[0131] Table 2 summarizes the formulations of the microcapsules prepared in Examples 21 to 24 above using Takenate D-110N isocyanate and sebacyl chloride as crosslinking agents, as well as the fragrance release of the capsules in hexane.
[0132] Table 2
[0133] The results shown in Tables 1 and 2 demonstrate that the release properties of the microcapsules can be established and controlled based on the selection of the capsule wall-forming material and its relative concentration, essentially enabling the preparation of customized release microcapsules. In this regard, once a small sample / library is established to correlate the selected capsule wall-forming component and its relative concentration with the release properties of a given microcapsule, the microcapsules can be customized for a given release characteristic by specifically selecting the capsule wall-forming component and its dosage.
[0134] Singular terms such as “an” and “a” are intended to cover both the singular and the plural unless otherwise stated herein or the context clearly contradicts them. The terms “comprising,” “having,” “including,” and “containing” should be interpreted as open-ended terms. Any description of certain embodiments as “preferred” embodiments, or any statement of an embodiment, feature, or scope as preferred, or implying that it is preferred, should not be considered limiting. All methods described herein can be carried out in any suitable order unless otherwise stated herein or the context clearly contradicts them. Any and all instances or exemplary language (e.g., “such as”) provided herein are intended to illustrate the invention and do not constitute a limitation on the scope of the invention. Any wording not claimed in the claims should not be considered limiting the scope of the invention. Any statement or implication herein that certain features constitute a part of the claimed invention is not intended to be limiting unless embodied in the appended claims.
[0135] While the methods and microcapsules prepared herein have been described with respect to specific embodiments and examples, it should be understood that this teaching is not limited thereto, and other embodiments utilizing the concepts expressed herein are contemplated and considered without departing from the scope of this teaching. Therefore, the true scope of this teaching is defined by the claimed method steps and any and all modifications, variations, or equivalents falling within the spirit and scope of the basic principles set forth herein.
Claims
1. A microcapsule comprising the reaction product of the following substances: A) One or more protein-based components selected from proteins, peptides, polypeptides, and combinations of any two or more of said proteins, peptides, and polypeptides. B) A crosslinking component comprising a combination of two or more crosslinking agents, at least one of which is i) an isocyanate component selected from the group consisting of one or more diisocyanates and / or polyisocyanates, and at least one of which is ii) a chlorine-containing component selected from the group consisting of a) diacyl chlorides and / or polyacyl chlorides, b) dichloroformates and / or polychloroformates and / or c) disulfonyl chlorides and / or polysulfonyl chlorides; wherein the weight ratio ((A):(B)) of the protein-based component (I) to the crosslinking component (B) is 100:1 to 1:100, and the weight ratio ((i):(ii)) of the isocyanate component (i) to the chlorine-containing component (ii) is 100:1 to 100:
50.
2. The microcapsule according to claim 1, wherein the weight ratio of the protein-based component (A) to the crosslinking component (B) is 10:1 to 1:
10.
3. The microcapsule according to claim 1, wherein the weight ratio of the protein-based component (A) to the crosslinking component (B) is 1:5 to 1:0.
2.
4. The microcapsule according to any one of claims 1 to 3, wherein the weight ratio ((i):(ii)) of the isocyanate component (i) to the chlorine-containing component (ii) is 100:5 to 100:
15.
5. The microcapsule according to any one of claims 1 to 4, wherein the protein-based component is an animal-based protein component or a synthetic equivalent thereof.
6. The microcapsule according to claim 5, wherein the animal-based protein component is selected from proteins, polypeptides, peptides, egg proteins, silk proteins, milk proteins, gelatin, and one or more combinations thereof.
7. The microcapsule according to any one of claims 1 to 4, wherein the protein-based component is a plant-based protein component or a synthetic equivalent thereof.
8. The microcapsule according to any one of claims 1 to 7, wherein the protein component is a protein of 10,000 Da to 110,000 Da.
9. The microcapsule according to any one of claims 1 to 7, wherein the protein component is a protein of 15,000 Da to about 40,000 Da.
10. The microcapsule according to any one of claims 1 to 7, wherein the protein component is a polypeptide having at least two amino acids and a molecular weight of less than 10,000 Da.
11. The microcapsule of claim 10, wherein the polypeptide comprises 5 to 50 amino acids.
12. The microcapsule according to any one of claims 1 to 11, wherein the protein component is a fragmented starting protein, whereby the median particle size D50 of the starting protein has been reduced by at least about 40%.
13. The microcapsule according to any one of claims 1 to 11, wherein the protein component is a fragmented starting protein, wherein the median particle size of the fragmented protein is about 0.1% to about 60% of the median particle size of the starting protein before fragmentation.
14. The microcapsule according to any one of claims 1 to 13, wherein the isocyanate component is an aliphatic, alicyclic, aromatic or polyaromatic isocyanate, or a dimer, trimer, oligomer or prepolymer thereof, or a combination of two or more such isocyanates.
15. The microcapsule according to any one of claims 1 to 14, wherein the isocyanate has 2 to 16 carbon atoms and 2 to 4 cyanate (NCO) groups in a basic hydrocarbon skeleton.
16. The microcapsule according to any one of claims 1 to 15, wherein the isocyanate component is a diisocyanate.
17. The microcapsule according to any one of claims 1 to 15, wherein the isocyanate component is a combination of diisocyanate and / or polyisocyanate.
18. The microcapsule according to any one of claims 1 to 15, wherein the isocyanate component is a combination of aliphatic and aromatic isocyanates.
19. The microcapsule according to any one of claims 1 to 15, wherein the isocyanate component is a combination of two or more isocyanates, wherein each is present in an amount of at least 10% by weight.
20. The microcapsule according to any one of claims 1 to 19, wherein the chlorine-containing component is one or more acyl chlorides.
21. The microcapsule of claim 20, wherein the acyl chloride has 4 to 12 carbon atoms and is selected from saturated or unsaturated straight-chain or branched aliphatic polybasic acids.
22. The microcapsule of claim 20, wherein the acyl chloride is selected from acetyl chloride, octyl chloride, azelaic chloride, sebacic chloride, dodecyl dichloride, isophthaloyl chloride, terephthaloyl chloride, 1,3,5-benzenetricarboxyl chloride, 1,2,4,5-benzenetetracarboxyl tetrachloride, and any combination of two or more of the foregoing.
23. The microcapsule according to any one of claims 1 to 19, wherein the chlorine-containing component is one or more dichloroformates and / or polychloroformates.
24. The microcapsule of claim 23, wherein the chloroformate is derived from a diol having 2 to 8 carbon atoms and a polyether diol having 2 to 6 carbon atoms and 2 to 8 repeating units.
25. The microcapsule according to claim 23, wherein the chloroformate is selected from ethylene bis(chloroformate), 1,4-butanediol bis(chloroformate), 1,6-hexanediol bis(chloroformate), tri(ethylene glycol) bis(chloroformate), diethylene glycol dichloroformate, diethylene glycol chloride, 1,4-phenylene bis(chloroformate), bisphenol A bis(chloroformate), and bisphenol Z bis(chloroformate).
26. The microcapsule according to any one of claims 1 to 19, wherein the chlorine-containing component is one or more disulfonyl chlorides and / or polysulfonyl chlorides.
27. The microcapsule of claim 26, wherein the sulfonyl chloride is selected from 1,3-benzene disulfonyl chloride, 1,4-benzene disulfonyl chloride, 1,3,5-benzene trisulfonyl chloride, 4,4'-biphenyl disulfonyl chloride, 4,4'-methylene bis(benzene sulfonyl chloride), 4,4'-bis(chlorosulfonyl) diphenyl ether, 1,5-naphthalene disulfonyl chloride, and 2,7-naphthalene disulfonyl chloride.
28. A method for forming microcapsules, comprising: Forming 1) an emulsion or dispersion of an aqueous phase composition and an oil phase composition, wherein the aqueous phase composition comprises (A) one or more protein-based components selected from proteins, peptides, polypeptides, and any combination of two or more of the proteins, peptides, and polypeptides, and the oil phase composition comprises (B) i) a combination of an isocyanate component and ii) a chlorine-containing component, wherein the isocyanate component is selected from the group consisting of one or more diisocyanates and / or polyisocyanates, and the chlorine-containing component is selected from the group consisting of a) diacyl chlorides and / or polyacyl chlorides, b) dichloroformates and / or polychloroformates and / or c) disulfonyl chlorides and / or polysulfonyl chlorides; Wherein (I) the weight ratio ((A):(B)) of the protein-based component (A) to the combination (B) is 100:1 to 1:100, and (II) the weight ratio ((i):(ii)) of the isocyanate component (i) to the chlorine-containing component (ii) is 100:1 to 100:50; and 2) the emulsion is subjected to conditions suitable for the polymerization and crosslinking of the protein with the isocyanate and the chlorine-containing component, and the reaction is sustained for a sufficient time to achieve the formation of the microcapsules.
29. The method of claim 28, wherein the method is an oil-in-water microencapsulation method, and the oil phase further comprises a core material.
30. An article comprising the microcapsules according to claim 1.
31. The article of claim 30, wherein the article is selected from the group consisting of: soaps, surface cleaners, laundry detergents, fabric softeners, shampoos, textiles, paper towels, adhesives, wipes, diapers, feminine hygiene products, facial tissues, pharmaceuticals, napkins, deodorants, radiators, foams, pillows, mattresses, bedding, cushions, cosmetics, medical devices, packaging, agricultural products, cooling fluids, wall panels, and insulating materials.
Citation Information
Patent Citations
Controlled release dual walled microcapsules
US10456766B2
High strength microcapsules
US10485739B2
Complexes of ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
US10675277B2
Biodegradable, controlled release microcapsules
US11952492B2
Process for Preparing a High Stability Microcapsule Product and Method for Using Same
US20070138673A1
